Mateus Crespo

5.8k total citations
44 papers, 1.0k citations indexed

About

Mateus Crespo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mateus Crespo has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Mateus Crespo's work include Prostate Cancer Treatment and Research (20 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mateus Crespo is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mateus Crespo collaborates with scholars based in United Kingdom, United States and Netherlands. Mateus Crespo's co-authors include Johann S. de Bono, Susana Miranda, Leon W.M.M. Terstappen, Diletta Bianchini, Gerhardt Attard, David Lorente, Joaquı́n Mateo, Daniel Nava Rodrigues, Penny Flohr and Ruth Riisnaes and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mateus Crespo

43 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mateus Crespo United Kingdom 17 525 421 399 393 97 44 1.0k
Stephanie M. McGregor United States 18 374 0.7× 345 0.8× 490 1.2× 245 0.6× 80 0.8× 52 1.3k
Erin Macrae United States 13 445 0.8× 708 1.7× 250 0.6× 360 0.9× 68 0.7× 20 1.0k
Wendy Onstenk Netherlands 19 397 0.8× 455 1.1× 257 0.6× 456 1.2× 86 0.9× 25 813
Frédérique Berger France 19 323 0.6× 517 1.2× 420 1.1× 411 1.0× 105 1.1× 64 1.0k
Pieter‐Jan van Dam Belgium 16 209 0.4× 335 0.8× 214 0.5× 278 0.7× 86 0.9× 37 684
Samantha Perakis Austria 11 324 0.6× 240 0.6× 367 0.9× 466 1.2× 74 0.8× 17 806
Penny Flohr United Kingdom 15 787 1.5× 390 0.9× 621 1.6× 543 1.4× 77 0.8× 27 1.3k
Dana Ghiorghiu United Kingdom 15 929 1.8× 808 1.9× 497 1.2× 171 0.4× 139 1.4× 36 1.4k
Tyler P. Robin United States 17 405 0.8× 608 1.4× 330 0.8× 198 0.5× 74 0.8× 55 1.3k

Countries citing papers authored by Mateus Crespo

Since Specialization
Citations

This map shows the geographic impact of Mateus Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mateus Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mateus Crespo more than expected).

Fields of papers citing papers by Mateus Crespo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mateus Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mateus Crespo. The network helps show where Mateus Crespo may publish in the future.

Co-authorship network of co-authors of Mateus Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Mateus Crespo. A scholar is included among the top collaborators of Mateus Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mateus Crespo. Mateus Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Matthew, Mateus Crespo, Bora Gürel, et al.. (2024). Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009368–e009368. 7 indexed citations
2.
Serrano‐Candelas, Eva, et al.. (2024). GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based tools. 1. 100005–100005. 1 indexed citations
3.
4.
Neeb, Antje, Ines Figueiredo, Bora Gürel, et al.. (2023). Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. Laboratory Investigation. 103(11). 100245–100245.
5.
Sheehan, Beshara, Antje Neeb, Lorenzo Buroni, et al.. (2022). Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research. 28(14). 3104–3115. 22 indexed citations
6.
Biondo, Andrea, Abhijit Pal, Ruth Riisnaes, et al.. (2021). Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation – a Single Unit Experience. Cancer Treatment and Research Communications. 27. 100309–100309. 2 indexed citations
7.
Slovin, Susan F., Syed A. Hussain, Fred Saad, et al.. (2019). Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer. Clinical Cancer Research. 25(15). 4624–4633. 31 indexed citations
8.
Rodrigues, Daniel Nava, Nicola Casiraghi, Alessandro Romanel, et al.. (2018). RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(2). 687–697. 44 indexed citations
9.
Nanou, Afroditi, Mateus Crespo, Penny Flohr, Johann S. de Bono, & Leon W.M.M. Terstappen. (2018). Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles. Cancers. 10(11). 416–416. 29 indexed citations
10.
Nanou, Afroditi, Frank Coumans, Guus van Dalum, et al.. (2018). Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients. Oncotarget. 9(27). 19283–19293. 54 indexed citations
11.
Lorente, David, David Olmos, Joaquı́n Mateo, et al.. (2018). Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Annals of Oncology. 29(7). 1554–1560. 72 indexed citations
12.
Lu, Miao, Lin Yang, Rui Li, et al.. (2017). Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial–Mesenchymal Plasticity in Prostate Cancer. Cancer Research. 77(11). 3101–3112. 66 indexed citations
13.
McNair, Christopher, Kexin Xu, Amy C. Mandigo, et al.. (2017). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation. 128(1). 341–358. 70 indexed citations
14.
Lorente, David, David Olmos, Joaquı́n Mateo, et al.. (2016). Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer. European Urology. 70(6). 985–992. 113 indexed citations
15.
Mehra, Niven, George Seed, Maryou Lambros, et al.. (2016). Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS). Annals of Oncology. 27. vi257–vi257. 6 indexed citations
16.
Crespo, Mateus, Guus van Dalum, Roberta Ferraldeschi, et al.. (2015). Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents. British Journal of Cancer. 112(7). 1166–1174. 53 indexed citations
17.
Box, Gary, Nina Tunariu, Mateus Crespo, et al.. (2014). Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib. JNCI Journal of the National Cancer Institute. 106(4). dju033–dju033. 51 indexed citations
18.
Bianchini, Diletta, Aurelius Omlin, Carmel Pezaro, et al.. (2013). First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. British Journal of Cancer. 109(10). 2579–2586. 72 indexed citations
19.
Carden, Craig P., Adam Stewart, Emma Kipps, et al.. (2012). The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer. Molecular Cancer Therapeutics. 11(7). 1609–1617. 81 indexed citations
20.
Cabrera, Rafael, Paula Chaves, Mateus Crespo, et al.. (2002). Adenocarcinoma of the esophagogastric junction: could the characteristics of adjacent intestinal metaplasia help in the understanding of biopathogenesis?. Diseases of the Esophagus. 15(4). 287–289. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie M. McGregor Breakdown of academic impact, for papers by Erin Macrae Breakdown of academic impact, for papers by Wendy Onstenk Breakdown of academic impact, for papers by Frédérique Berger Breakdown of academic impact, for papers by Pieter‐Jan van Dam Breakdown of academic impact, for papers by Samantha Perakis Breakdown of academic impact, for papers by Penny Flohr Breakdown of academic impact, for papers by Dana Ghiorghiu Breakdown of academic impact, for papers by Tyler P. Robin
Rankless by CCL
2026